background
coronaviru
diseas
tradit
fever
treat
metabol
cost
felt
outweigh
potenti
physiolog
benefit
alreadi
stress
host
howev
increas
data
suggest
fever
may
protect
adapt
respons
allow
run
cours
circumst
higher
earli
fever
associ
lower
risk
death
among
patient
icu
admiss
diagnosi
infect
fever
may
enhanc
immunecel
function
inhibit
pathogen
growth
increas
activ
antimicrobi
drug
fever
potenti
benefit
infect
patient
via
multipl
mechan
vitro
anim
studi
shown
elev
temperatur
augment
immun
function
increas
product
protect
heat
shock
protein
directli
inhibit
microorgan
growth
reduc
viral
replic
enhanc
antibiot
effect
rapid
recoveri
observ
chickenpox
malaria
rhinoviru
infect
avoid
antipyret
medic
mani
innat
adapt
immunolog
process
acceler
fever
random
control
trial
consist
fail
find
benefit
treat
fever
infecti
etiolog
retrospect
cohort
studi
evalu
patient
requir
mechan
ventil
found
high
fever
associ
increas
risk
mortal
mechan
ventil
patient
howev
patient
sepsi
moder
fever
protect
antipyret
medic
associ
chang
outcom
recent
malaria
fever
cure
induc
fever
treat
rang
condit
approach
known
pyrotherapi
widespread
origin
idea
receiv
nobel
prize
medicin
physiolog
current
uk
nation
institut
health
care
excel
nice
recommend
use
antipyret
agent
sole
aim
reduc
bodi
temperatur
children
fever
activ
induc
hyperthermia
directli
heat
bodi
use
cancer
treatment
minim
advers
effect
hyperthermia
found
posit
impact
immun
system
caus
increas
level
heatshock
protein
directli
relat
antigen
present
crosspresent
activ
macrophag
lymphocyt
activ
matur
dendrit
cell
pilot
studi
extern
warm
septic
patient
clinicaltrialsgov
identifi
recent
complet
mani
virus
replic
robustli
cooler
temperatur
found
nasal
caviti
warmer
core
bodi
temperatur
coronaviru
diseas
caus
viru
may
behav
similarli
simul
receptor
bind
domain
rbd
found
high
flexibl
near
bind
site
ccbi
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
suggest
rbd
high
entropi
penalti
upon
bind
angiotensinconvert
enzym
ii
consequ
viru
may
temperaturesensit
term
human
infect
coronavirus
notabl
fever
often
abat
time
patient
requir
mechan
ventil
aim
studi
determin
effect
activ
core
warm
patient
diagnos
undergo
mechan
ventil
hypothes
activ
core
warm
reduc
sever
acut
respiratori
distress
syndrom
reduc
durat
mechan
ventil
improv
surviv
compar
standard
care
purpos
propos
pilot
studi
determin
core
warm
improv
respiratori
physiolog
mechan
ventil
patient
allow
earlier
wean
ventil
greater
overal
surviv
measur
impact
esophag
core
warm
sever
acut
respiratori
distress
syndrom
measur
ratio
hour
initi
compar
standard
care
compar
durat
mechan
ventil
patient
treat
core
warm
patient
treat
standard
care
compar
length
icu
hospit
stay
patient
treat
core
warm
patient
treat
standard
care
compar
viral
shed
day
hospit
patient
treat
core
warm
patient
treat
standard
care
compar
mortal
patient
treat
core
warm
patient
treat
standard
care
singlecent
pilot
studi
evalu
core
warm
improv
respiratori
physiolog
mechan
ventil
patient
allow
earlier
wean
ventil
greater
overal
surviv
prospect
random
studi
includ
patient
diagnos
undergo
mechan
ventil
treatment
respiratori
failur
patient
random
fashion
patient
group
random
undergo
core
warm
esophag
heat
transfer
devic
patient
group
b
serv
control
group
patient
random
group
esophag
heat
transfer
devic
place
icu
clinic
environ
treat
enrol
provis
inform
consent
appropri
surrog
legal
author
repres
subject
recruit
icu
clinic
environ
treat
emerg
depart
stepdown
unit
etc
patient
identifi
pi
studi
investigatorscoordin
avail
patient
without
dnr
order
diagnosi
meet
inclus
criteria
elig
screen
exclus
criteria
written
inform
consent
research
studi
obtain
patient
surrog
legal
author
repres
prior
enrol
particip
sign
research
studi
consent
form
via
surrog
legal
author
repres
random
fashion
core
warm
standard
care
standard
temperatur
manag
treatment
esophag
heat
transfer
devic
use
accord
fda
k
label
patient
warm
patient
temperatur
measur
collect
devic
standardofcar
arm
studi
period
hour
devic
placement
perform
use
standard
protocol
per
instruct
use
esophag
heat
transfer
devic
set
temperatur
initi
placement
maintain
durat
treatment
patient
usual
standard
care
lab
vital
sign
imag
patient
critic
condit
undergo
mechan
ventil
icu
specif
paramet
measur
includ
regular
interv
appropri
patient
undergo
mechan
ventil
time
obtain
blood
gase
measur
allow
calcul
pf
ratio
purpos
pilot
studi
determin
core
warm
reduc
sever
acut
respiratori
distress
syndrom
measur
ratio
measur
compar
time
point
hour
initi
primari
endpoint
studi
ratio
secondari
studi
endpoint
includ
durat
mechan
ventil
durat
icu
hospit
stay
amount
viral
shed
patient
mortal
patient
age
year
old
ccbi
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
subject
recruit
icu
clinic
environ
treat
emerg
depart
stepdown
unit
etc
patient
identifi
pi
studi
investigatorscoordin
avail
patient
without
dnr
order
diagnosi
meet
inclus
criteria
elig
screen
exclus
criteria
written
inform
consent
research
studi
obtain
patient
surrog
legal
author
repres
prior
enrol
patient
enrol
studi
gain
capac
consent
himherself
studi
progress
patient
approach
studi
team
member
consent
document
present
directli
patient
question
patient
might
answer
patient
given
opportun
either
withdraw
studi
sign
consent
form
patient
inform
decis
withdraw
studi
affect
medic
care
particip
involv
approxim
month
includ
screen
treatment
followup
consent
patient
particip
intervent
phase
last
hour
activ
treatment
follow
determin
outcom
durat
mechan
ventil
occur
posttreat
addit
data
collect
via
chart
review
singlesit
studi
aim
recruit
random
patient
expect
subject
may
consent
order
produc
random
evalu
subject
ccbi
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
core
temperatur
control
warm
perform
commerci
avail
esophag
heat
exchang
devic
ensoetm
attun
medic
chicago
il
devic
current
use
worldwid
variou
patient
temperatur
manag
goal
includ
postcardiac
arrest
therapeut
hypothermia
warm
burn
patient
warm
gener
surgic
patient
cool
traumat
brain
injuri
cool
heat
stroke
treatment
central
fever
devic
multichamb
silicon
tube
place
esophagu
connect
heat
exchang
provid
heat
transfer
patient
video
avail
http
modul
control
patient
temperatur
achiev
adjust
setpoint
extern
heat
exchang
turn
control
circul
water
temperatur
two
lumen
devic
connect
extern
heat
exchang
third
central
lumen
provid
stomach
access
gastric
decompress
tube
feed
singleus
dispos
nonimplant
devic
intend
durat
use
hour
less
patient
random
core
warm
esophag
heat
transfer
devic
place
icu
treatment
area
patient
undergo
mechan
ventil
devic
remain
place
studi
complet
hour
devic
set
durat
studi
period
expect
patient
temperatur
increas
baselin
due
ongo
heat
loss
patient
expect
maximum
patient
temperatur
time
cours
ill
patient
longer
fever
time
mechan
ventil
patient
temperatur
increas
rang
reach
devic
set
oper
temperatur
therebi
prevent
increas
patient
temperatur
patient
temperatur
follow
interv
per
standard
care
intensivecar
set
mechan
ventil
patient
typic
hourli
due
natur
studi
physician
blind
random
assign
howev
particip
blind
subject
random
research
team
receiv
random
assign
core
warm
standard
care
proceed
procedur
per
assign
demograph
includ
sexgend
race
ethnic
age
via
date
birth
past
medic
histori
social
histori
physic
exam
find
physician
note
concurr
medic
physic
exam
vital
sign
temperatur
blood
pressur
heart
rate
respir
rate
height
weight
ccbi
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
clinic
lab
complet
blood
count
cbc
chemistri
profil
liver
function
test
inflammatori
marker
crp
ferritin
ddimer
arteri
blood
ga
determin
upper
nasopharyng
lower
tracheal
aspir
sputum
respiratori
tract
viral
load
cycl
threshold
sever
ill
apach
iii
sequenti
organ
failur
assess
sofa
score
system
ventil
set
pregnanc
test
women
childbear
age
advers
event
unanticip
problem
data
collect
via
chart
review
expect
avail
routin
obtain
laboratori
vital
sign
data
record
routin
interv
ie
lab
drawn
routin
care
icu
primari
endpoint
studi
chang
ratio
hour
implement
core
warm
ventil
patient
endpoint
compar
patient
receiv
core
warm
random
undergo
standard
care
standard
temperatur
manag
typic
antipyret
need
secondari
endpoint
includ
durat
mechan
ventil
durat
icu
hospit
stay
amount
viral
shed
patient
mortal
base
prior
studi
patient
sepsi
maximum
temperatur
associ
surviv
ahr
ci
howev
effect
warm
specif
patient
remain
uncertain
unabl
accur
perform
power
calcul
pilot
studi
believ
total
patient
group
requir
yield
necessari
pilot
data
make
appropri
conclus
regard
potenti
util
core
warm
improv
pulmonari
physiolog
reduc
mechan
ventil
durat
increas
patient
surviv
anticip
data
pilot
studi
use
plan
futur
larger
studi
util
standard
measur
report
outcom
measur
differ
group
specif
use
descript
statist
includ
mean
standard
deviat
median
interquartil
rang
normal
assess
use
histogram
kolmogorovsmirnov
test
categor
variabl
compar
use
chisquar
test
fisher
exact
test
continu
variabl
compar
use
independ
sampl
mannwhitney
u
test
pilot
studi
determin
potenti
role
core
warm
treatment
ccbi
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
subject
enter
studi
random
baselin
timepoint
detail
inform
collect
advers
event
overal
studi
safeti
analysi
interim
safeti
analysi
perform
first
subject
enrol
trial
time
safeti
toler
studi
devic
assess
deem
safe
appropri
enrol
continu
subject
patient
enrol
random
studi
arm
complet
studi
includ
analysi
describ
initi
data
collect
approach
obtain
analyz
data
pilot
randomizedcontrol
trial
core
warm
patient
undergo
mechan
ventil
due
anticip
framework
enhanc
util
report
result
provid
solid
basi
design
execut
subsequ
investig
